Genmab A/S (GNMSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 52,286 | 428,564 | 134,671 | 30,805 | 14,310 |
| Depreciation Amortization | N/A | 20,836 | N/A | N/A | N/A |
| Accounts receivable | N/A | -248,534 | N/A | N/A | N/A |
| Other Working Capital | 310,465 | -182,578 | 84,480 | 104,865 | 111,256 |
| Other Operating Activity | -38,993 | 180,480 | -47,638 | -10,367 | -27,063 |
| Operating Cash Flow | $323,758 | $198,767 | $171,513 | $125,303 | $98,503 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 9,896 | -280,613 | -111,776 | -113,027 | 1,192 |
| PPE Investments | -8,567 | -11,842 | -8,752 | -5,357 | -3,252 |
| Purchase Sale Intangibles | N/A | -4,797 | -3,488 | N/A | N/A |
| Other Investing Activity | 0 | -4,797 | -3,488 | 0 | 0 |
| Investing Cash Flow | $1,329 | $-297,252 | $-124,016 | $-118,384 | $-2,060 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,465 | 590,306 | 583,767 | 5,824 | 820 |
| Other Financing Activity | -3,249 | -41,672 | -39,523 | -3,472 | -2,419 |
| Financing Cash Flow | $2,216 | $548,634 | $544,245 | $2,352 | $-1,598 |
| Exchange Rate Effect | 7,828 | 2,398 | 20,668 | -1,748 | 3,157 |
| Beginning Cash Position | 483,570 | 79,897 | 79,403 | 80,256 | 81,108 |
| End Cash Position | 818,701 | 532,445 | 691,812 | 87,779 | 179,111 |
| Net Cash Flow | $335,131 | $452,548 | $612,409 | $7,523 | $98,003 |
| Free Cash Flow | |||||
| Operating Cash Flow | 323,758 | 198,767 | 171,513 | 125,303 | 98,503 |
| Capital Expenditure | -8,567 | -11,842 | -8,752 | -5,357 | -3,252 |
| Free Cash Flow | 315,192 | 186,925 | 162,762 | 119,946 | 95,252 |